Query Trace: Hereditary cancer[orginal query]
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.  Journal of the National Cancer Institute 2018 Feb . Lowery Maeve A, Wong Winston, Jordan Emmet J, Lee Jonathan W, Kemel Yelena, Vijai Joseph, Mandelker Diana, Zehir Ahmet, Capanu Marinela, Salo-Mullen Erin, Arnold Angela G, Yu Kenneth H, Varghese Anna M, Kelsen David P, Brenner Robin, Kaufmann Erica, Ravichandran Vignesh, Mukherjee Semanti, Berger Michael F, Hyman David M, Klimstra David S, Abou-Alfa Ghassan K, Tjan Catherine, Covington Christina, Maynard Hannah, Allen Peter J, Askan Gokce, Leach Steven D, Iacobuzio-Donahue Christine A, Robson Mark E, Offit Kenneth, Stadler Zsofia K, O'Reilly Eileen |
| No Evidence for the Pathogenicity of the BRCA2 c.6937?+?594T>G Deep Intronic Variant: A Case-Control Analysis. Genetic testing and molecular biomarkers 2018 Jan . Dutil Julie, Godoy Lenin, Rivera-Lugo Rafael, Arroyo Nelly, Albino Elinette, Negrón Luis, Monteiro Alvaro N, Matta Jaime L, Echenique Migu |
| Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland. Hereditary cancer in clinical practice 2018 16 6. Kluz Tomasz, Jasiewicz Andrzej, Marczyk El?bieta, Jach Robert, Jakubowska Anna, Lubi?ski Jan, Narod Steven A, Gronwald Jac |
| Men seeking counselling in a Breast Cancer Risk Evaluation Clinic. Ecancermedicalscience 2018 12 804. Freitas Ana Catarina, Opinião Ana, Fragoso Sofia, Nunes Hugo, Santos Madalena, Clara Ana, Bento Sandra, Luis Ana, Silva Jorge, Moura Cecília, Filipe Bruno, Machado Patrícia, Santos Sidónia, André Saudade, Rodrigues Paula, Parreira Joana, Vaz Fáti |
| Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development. Journal of molecular medicine (Berlin, Germany) 2017 Jan . Villacis Rolando A R, Basso Tatiane R, Canto Luisa M, Pinheiro Maísa, Santiago Karina M, Giacomazzi Juliana, de Paula Cláudia A A, Carraro Dirce M, Ashton-Prolla Patrícia, Achatz Maria I, Rogatto Silvia |
| ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis. Hereditary cancer in clinical practice 2017 15 8. Jiang Yan, Zhao Chen-Yang, Cheng Li-Chun, Xu Bing, Lv Hui- |
| Clinical and genetic characterization of hereditary breast cancer in a Chinese population. Hereditary cancer in clinical practice 2017 15 19. Jian Wenjing, Shao Kang, Qin Qi, Wang Xiaohong, Song Shufen, Wang Xianmi |
| The BRCA2 variant c.68-7 T>A is associated with breast cancer. Hereditary cancer in clinical practice 2017 15 20. Møller Pål, Hovig Eivi |
| Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Nov 29 (11): 1381-1389. Ring Kari L, Bruegl Amanda S, Allen Brian A, Elkin Eric P, Singh Nanda, Hartman Anne-Renee, Daniels Molly S, Broaddus Russell |
| Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients. Cancer genetics 2016 Nov 209 (11): 497-500. Liu Qing, Hesson Luke B, Nunez Andrea C, Packham Deborah, Hawkins Nicholas J, Ward Robyn L, Sloane Mathew |
| Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Oncology reports 2016 Sep . Lagerstedt-Robinson Kristina, Rohlin Anna, Aravidis Christos, Melin Beatrice, Nordling Margareta, Stenmark-Askmalm Marie, Lindblom Annika, Nilbert M |
| Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes. Surgical pathology clinics 2016 Jun 9 (2): 189-99. Nakonechny Quentin B, Gilks C Bla |
| Germline Analysis from Tumor-Germline Sequencing Dyads to identify clinically actionable secondary findings. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Apr . Seifert Bryce A, O'Daniel Julianne M, Amin Krunal, Marchuk Daniel S, Patel Nirali M, Parker Joel S, Hoyle Alan P, Mose Lisle E, Marron Andrew, Hayward Michele C, Bizon Christopher, Wilhelmsen Kirk C, Evans James P, Earp H Shelton, Sharpless Ned, Hayes D Neil, Berg Jonathan |
| Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing. Cancer biology & medicine 2016 Mar 13 (1): 55-67. Stanislaw Christine, Xue Yuan, Wilcox William |
| Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes. Hereditary cancer in clinical practice 2016 14 2. Fernandes Gabriela C, Michelli Rodrigo A D, Scapulatempo-Neto Cristovam, Palmero Edenir |
| Autism Linked to Increased Oncogene Mutations but Decreased Cancer Rate. PloS one 2016 11 (3): e0149041. Darbro Benjamin W, Singh Rohini, Zimmerman M Bridget, Mahajan Vinit B, Bassuk Alexander |
| BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population. Hereditary cancer in clinical practice 2016 14 3. ?awniczak Ma?gorzata, Jakubowska Anna, Bia?ek Andrzej, Lubi?ski Jan, Jaworska-Bieniek Katarzyna, Kaczmarek Katarzyna, Starzy?ska Tere |
| Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients. Hereditary cancer in clinical practice 2016 14 13. Bennedbæk Marc, Rossing Maria, Rasmussen Åse K, Gerdes Anne-Marie, Skytte Anne-Bine, Jensen Uffe B, Nielsen Finn C, Hansen Thomas V |
| Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality. Hereditary cancer in clinical practice 2016 14 8. Evans D G, Harkness E F, Howell A, Wilson M, Hurley E, Holmen M M, Tharmaratnam K U, Hagen A I, Lim Y, Maxwell A J, Moller |
| PALB2: research reaching to clinical outcomes for women with breast cancer. Hereditary cancer in clinical practice 2016 14 9. Southey Melissa C, Winship Ingrid, Nguyen-Dumont |
| Prevalence of the CHEK2 R95* germline mutation. Hereditary cancer in clinical practice 2016 14 19. Knappskog Stian, Leirvaag Beryl, Gansmo Liv B, Romundstad Pål, Hveem Kristian, Vatten Lars, Lønning Per |
| Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland. Hereditary cancer in clinical practice 2016 14 5. Wojcik P, Jasiowka M, Strycharz E, Sobol M, Hodorowicz-Zaniewska D, Skotnicki P, Byrski T, Blecharz P, Marczyk E, Cedrych I, Jakubowicz J, Lubi?ski J, Sopik V, Narod S, Pierzchalski |
| Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast cancer research and treatment 2015 Dec . Ngeow Joanne, Sesock Kaitlin, Eng Char |
| Genetic analysis in a patient with nine primary malignant neoplasms: a rare case of Li-Fraumeni syndrome. Oncology reports 2015 Dec . Li Xiaoyuan, Kang Juan, Pan Qi, Sikora-Wohlfeld Weronika, Zhao Dachun, Meng Changting, Bai Chunmei, Patwardhan Anil, Chen Richard, Ren Hong, Butte Atul J, Ding Key |
| Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis. Familial cancer 2015 Dec . de Oliveira Eneida Santos, Soares Bárbara Luisa, Lemos Sara, Rosa Reginaldo Cruz Alves, Rodrigues Angélica Nogueira, Barbosa Leandro Augusto, de Oliveira Lopes Débora, Dos Santos Luciana La |
| Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer. Annals of surgical oncology 2015 Oct 22 (10): 3282-8. Kapoor Nimmi S, Curcio Lisa D, Blakemore Carlee A, Bremner Amy K, McFarland Rachel E, West John G, Banks Kimberly |
| Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Gastroenterology 2015 Sep 149 (3): 604-613.e20. Yurgelun Matthew B, Allen Brian, Kaldate Rajesh R, Bowles Karla R, Judkins Thaddeus, Kaushik Praveen, Roa Benjamin B, Wenstrup Richard J, Hartman Anne-Renee, Syngal Sap |
| Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer. Molecular genetics & genomic medicine 2015 Sep 3 (5): 459-66. Hirotsu Yosuke, Nakagomi Hiroshi, Sakamoto Ikuko, Amemiya Kenji, Oyama Toshio, Mochizuki Hitoshi, Omata Mas |
| Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature. Journal of gastrointestinal cancer 2015 Jun 46 (2): 118-25. Zeinalian Mehrdad, Emami Mohammad Hassan, Salehi Rasoul, Naimi Azar, Kazemi Mohammad, Hashemzadeh-Chaleshtori Morte |
| Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer. Scientific reports 2015 5 14060. de Voer Richarda M, Hahn Marc-Manuel, Mensenkamp Arjen R, Hoischen Alexander, Gilissen Christian, Henkes Arjen, Spruijt Liesbeth, van Zelst-Stams Wendy A, Marleen Kets C, Verwiel Eugene T, Nagtegaal Iris D, Schackert Hans K, van Kessel Ad Geurts, Hoogerbrugge Nicoline, Ligtenberg Marjolijn J L, Kuiper Roland |
| Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk. BMC cancer 2015 15 215. Judkins Thaddeus, Leclair Benoît, Bowles Karla, Gutin Natalia, Trost Jeff, McCulloch James, Bhatnagar Satish, Murray Adam, Craft Jonathan, Wardell Bryan, Bastian Mark, Mitchell Jeffrey, Chen Jian, Tran Thanh, Williams Deborah, Potter Jennifer, Jammulapati Srikanth, Perry Michael, Morris Brian, Roa Benjamin, Timms Kirst |
| Germline TP53 mutational spectrum in French Canadians with breast cancer. BMC medical genetics 2015 16 24. Arcand Suzanna L, Akbari Mohammed R, Mes-Masson Anne-Marie, Provencher Diane, Foulkes William D, Narod Steven A, Tonin Patricia |
| Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing. PloS one 2015 10 (4): e0125571. Yang Xiaochen, Wu Jiong, Lu Jingsong, Liu Guangyu, Di Genhong, Chen Canming, Hou Yifeng, Sun Menghong, Yang Wentao, Xu Xiaojing, Zhao Ying, Hu Xin, Li Daqiang, Cao Zhigang, Zhou Xiaoyan, Huang Xiaoyan, Liu Zhebin, Chen Huan, Gu Yanzi, Chi Yayun, Yan Xia, Han Qixia, Shen Zhenzhou, Shao Zhimin, Hu Zh |
| Ten modifiers of BRCA1 penetrance validated in a Norwegian series. Hereditary cancer in clinical practice 2015 13 (1): 14. Heramb Cecilie, Ekstrøm Per Olaf, Tharmaratnam Kukatharmini, Hovig Eivind, Møller Pål, Mæhle Lovi |
| The c.470 T?>?C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population. Hereditary cancer in clinical practice 2015 13 (1): 8. Kaczmarek-Ry? Marta, Ziemnicka Katarzyna, Hryhorowicz Szymon T, Górczak Katarzyna, Hoppe-Go??biewska Justyna, Skrzypczak-Zieli?ska Marzena, Tomys Michalina, Go??b Monika, Szkudlarek Malgorzata, Budny Bart?omiej, Siatkowski Idzi, Gut Pawe?, Rucha?a Marek, S?omski Ryszard, P?awski Andrz |
| Most common 'sporadic' cancers have a significant germline genetic component. Human molecular genetics 2014 Nov 23 (22): 6112-8. Lu Yi, Ek Weronica E, Whiteman David, Vaughan Thomas L, Spurdle Amanda B, Easton Douglas F, Pharoah Paul D, Thompson Deborah J, Dunning Alison M, Hayward Nicholas K, Chenevix-Trench Georgia, , , , , Macgregor Stua |
| Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genetics in medicine : official journal of the American College of Medical Genetics 2014 Nov 16 (11): 830-7. LaDuca Holly, Stuenkel A J, Dolinsky Jill S, Keiles Steven, Tandy Stephany, Pesaran Tina, Chen Elaine, Gau Chia-Ling, Palmaer Erika, Shoaepour Kamelia, Shah Divya, Speare Virginia, Gandomi Stephanie, Chao Elizabe |
| Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Jul 32 (19): 2001-9. Kurian Allison W, Hare Emily E, Mills Meredith A, Kingham Kerry E, McPherson Lisa, Whittemore Alice S, McGuire Valerie, Ladabaum Uri, Kobayashi Yuya, Lincoln Stephen E, Cargill Michele, Ford James |
| RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Familial cancer 2014 Jun 13 (2): 173-80. Krivokuca Ana M, Malisic Emina J, Dobricic Jelena D, Brotto Ksenija V, Cavic Milena R, Jankovic Radmila N, Tomasevic Zorica I, Brankovic-Magic Mirjana |
| Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations. Journal of genetic counseling 2014 Apr 23 (2): 187-91. Cossack Matthew, Ghaffary Cameron, Watson Patrice, Snyder Carrie, Lynch Hen |
| Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk. Archives of dermatological research 2014 Apr 306 (3): 231-8. D?bniak T, Soczawa E, Boer M, Ró?ewicka-Czaba?ska M, Wi?niewska J, Serrano-Fernandez P, Mirecka A, Paszkowska-Szczur K, Lubinski J, Krysztoforska L, Adamski Z, Maleszka |
| The presence of prostate cancer at biopsy is predicted by a number of genetic variants. International journal of cancer. Journal international du cancer 2014 Mar 134 (5): 1139-46. Kashyap Aniruddh, Klu?niak Wojciech, Woko?orczyk Dominika, Go??b Adam, Sikorski Andrzej, S?ojewski Marcin, Gliniewicz Bart?omiej, ?wita?a Jerzy, Borkowski Tomasz, Borkowski Andrzej, Antczak Andrzej, Wojnar ?ukasz, Przyby?a Jacek, Sosnowski Marek, Ma?kiewicz Bartosz, Zdrojowy Romuald, Sikorska-Radek Paulina, Matych Józef, Wilkosz Jacek, Ró?a?ski Waldemar, Ki? Jacek, Bar Krzysztof, Bryniarski Piotr, Paradysz Andrzej, Jersak Konrad, Niemirowicz Jerzy, S?upski Piotr, Jarzemski Piotr, Skrzypczyk Micha?, Dobruch Jakub, Domaga?a Pawe?, Piotrowski Krzysztof, Jakubowska Anna, Gronwald Jacek, Huzarski Tomasz, Byrski Tomasz, D?bniak Tadeusz, Górski Bohdan, Masoj? Bart?omiej, van de Wetering Thierry, Menkiszak Janusz, Akbari Mohammad R, Lubi?ski Jan, Narod Steven A, Cybulski Cezary, |
| GALNT12 is not a major contributor of familial colorectal cancer type X. Human mutation 2014 Jan 35 (1): 50-2. Seguí Nuria, Pineda Marta, Navarro Matilde, Lázaro Conxi, Brunet Joan, Infante Mar, Durán Mercedes, Soto José Luis, Blanco Ignacio, Capellá Gabriel, Valle Lau |
| [Effectiveness of platinum-based chemotherapy in ovarian cancer patients with BRCA1/2 mutations]. Voprosy onkologii 2014 60 (3): 339-42. Gorodnova T V, Maksimov S Ia, Guse?nov K D, Imianitov E |
| A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland. Hereditary cancer in clinical practice 2014 12 (1): 10. B?k Aneta, Janiszewska Hanna, Junkiert-Czarnecka Anna, Heise Marta, Pilarska-Deltow Maria, Laskowski Ryszard, Pasi?ska Magdalena, Haus Ol |
| Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes. Journal of experimental & clinical cancer research : CR 2014 33 74. Mancini-DiNardo Debora, Judkins Thaddeus, Woolstenhulme Nick, Burton Collin, Schoenberger Jeremy, Ryder Matthew, Murray Adam, Gutin Natalia, Theisen Aaron, Holladay Jayson, Craft Jonathan, Arnell Christopher, Moyes Kelsey, Roa Benjam |
| Dupuytren's disease and the risk of malignant neoplasms. Hereditary cancer in clinical practice 2014 12 (1): 6. Zyluk Andrzej, Paszkowska-Szczur Katarzyna, Gupta Satish, Scott Rodney J, Lubi?ski Jan, D?bniak Tadeu |
| Expanding the genetic basis of copy number variation in familial breast cancer. Hereditary cancer in clinical practice 2014 12 (1): 15. Masson Amy L, Talseth-Palmer Bente A, Evans Tiffany-Jane, Grice Desma M, Hannan Garry N, Scott Rodney |
| Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada. Hereditary cancer in clinical practice 2014 12 (1): 19. Hartley Taila, Cavallone Luca, Sabbaghian Nelly, Silva-Smith Rachel, Hamel Nancy, Aleynikova Olga, Smith Erika, Hastings Valerie, Pinto Pedro, Tischkowitz Marc, Tomiak Eva, Foulkes William |
| Plasma homocysteine levels and genetic polymorphisms in folate metablism are associated with breast cancer risk in chinese women. Hereditary cancer in clinical practice 2014 12 (1): 2. Wu Xiayu, Zou Tianning, Cao Neng, Ni Juan, Xu Weijiang, Zhou Tao, Wang |
| Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia. Hereditary cancer in clinical practice 2014 12 (1): 11. Hernández Julián Esteban Londoño, Llacuachaqui Marcia, Palacio Gonzalo Vásquez, Figueroa Juan David, Madrid Jorge, Lema Mauricio, Royer Robert, Li Song, Larson Garrett, Weitzel Jeffrey N, Narod Steven |
| Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil. PloS one 2014 9 (6): e99893. Giacomazzi Juliana, Graudenz Marcia S, Osorio Cynthia A B T, Koehler-Santos Patricia, Palmero Edenir I, Zagonel-Oliveira Marcelo, Michelli Rodrigo A D, Scapulatempo Neto Cristovam, Fernandes Gabriela C, Achatz Maria Isabel W S, Martel-Planche Ghyslaine, Soares Fernando A, Caleffi Maira, Goldim José Roberto, Hainaut Pierre, Camey Suzi A, Ashton-Prolla Patric |
| Screening of RB1 gene mutations in Chinese patients with retinoblastoma and preliminary exploration of genotype-phenotype correlations. Molecular vision 2014 20 545-52. He Ming-yan, An Yu, Gao Yi-jin, Qian Xiao-wen, Li Gang, Qian Jia |
| Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast. Hereditary cancer in clinical practice 2014 12 (1): 17. Valente Allyson L, Rummel Seth, Shriver Craig D, Ellsworth Rachel |
| TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
| Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry. Familial cancer 2013 Dec 12 (4): 719-40. Casey Murray Joseph, Bewtra Chhanda, Lynch Henry T, Snyder Carrie, Stacy Mark, Watson Patri |
| Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Nov 31 (31): 3914-9. Valentini Adriana, Finch Amy, Lubinski Jan, Byrski Tomasz, Ghadirian Parviz, Kim-Sing Charmaine, Lynch Henry T, Ainsworth Peter J, Neuhausen Susan L, Greenblatt Ellen, Singer Christian, Sun Ping, Narod Steven |
| Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Annals of surgical oncology 2013 Oct 20 (10): 3254-8. Greenup Rachel, Buchanan Adam, Lorizio Wendy, Rhoads Keelia, Chan Salina, Leedom Tracey, King Robin, McLennan Jane, Crawford Beth, Kelly Marcom P, Shelley Hwang |
| Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing. Clinical colorectal cancer 2013 Sep 12 (3): 168-78. Cushman-Vokoun Allison M, Stover Daniel G, Zhao Zhiguo, Koehler Elizabeth A, Berlin Jordan D, Vnencak-Jones Cindy |
| Xeroderma pigmentosum genes and melanoma risk. International journal of cancer. Journal international du cancer 2013 Sep 133 (5): 1094-100. Paszkowska-Szczur K, Scott R J, Serrano-Fernandez P, Mirecka A, Gapska P, Górski B, Cybulski C, Maleszka R, Sulikowski M, Nagay L, Lubinski J, D?bniak |
| A personalised approach to prostate cancer screening based on genotyping of risk founder alleles. British journal of cancer 2013 Jun 108 (12): 2601-9. Cybulski C, Woko?orczyk D, Klu?niak W, Kashyap A, Go??b A, S?ojewski M, Sikorski A, Puszy?ski M, Soczawa M, Borkowski T, Borkowski A, Antczak A, Przyby?a J, Sosnowski M, Ma?kiewicz B, Zdrojowy R, Domaga?a P, Piotrowski K, Menkiszak J, Krzystolik K, Gronwald J, Jakubowska A, Górski B, D?bniak T, Masoj? B, Huzarski T, Muir K R, Lophatananon A, Lubi?ski J, Narod S A, |
| Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer. Medical oncology (Northwood, London, England) 2013 Jun 30 (2): 545. Moiseyenko Vladimir M, Volkov Nikita M, Suspistin Evgeny N, Yanus Grigoriy A, Iyevleva Aglaya G, Kuligina Ekatherina Sh, Togo Alexandr V, Kornilov Alexandr V, Ivantsov Alexandr O, Imyanitov Evgeny |
| Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome. European journal of human genetics : EJHG 2013 May 21 (5): 511-6. Bellido Fernando, Guinó Elisabet, Jagmohan-Changur Shantie, Seguí Nuria, Pineda Marta, Navarro Matilde, Lázaro Conxi, Blanco Ignacio, Vasen Hans F A, Moreno Victor, Capellá Gabriel, Wijnen Juul T, Valle Lau |
| Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome. Journal of the National Cancer Institute 2013 Feb . Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J, Macrae FA, Parry S, Kalady MF, Baron JA, Ahnen DJ, Marchand LL, Gallinger S, Haile RW, Newcomb PA, Hopper JL, Jenkins MA |
| BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 2013 Jan 119 (2): 332-8. Pennington Kathryn P, Walsh Tom, Lee Ming, Pennil Christopher, Novetsky Akiva P, Agnew Kathy J, Thornton Anne, Garcia Rochelle, Mutch David, King Mary-Claire, Goodfellow Paul, Swisher Elizabeth |
| The risk of gastric cancer in carriers of CHEK2 mutations. Familial cancer 2013 Jan . Teodorczyk U, Cybulski C, Woko?orczyk D, Jakubowska A, Starzy?ska T, Lawniczak M, Domaga?a P, Ferenc K, Marlicz K, Banaszkiewicz Z, Wi?niowski R, Narod SA, Lubi?ski J |
| Comparison of whole genome amplification and nested-PCR methods for preimplantation genetic diagnosis for BRCA1 gene mutation on unfertilized oocytes-a pilot study. Hereditary cancer in clinical practice 2013 11 (1): 10. Michalska Danuta, Jaguszewska Kinga, Liss Joanna, Kitowska Kamila, Mirecka Agata, Lukaszuk Krzyszt |
| PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? The oncologist 2013 18 (10): 1083-90. Mester Jessica L, Moore Rebekah A, Eng Char |
| The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study. Hereditary cancer in clinical practice 2013 11 (1): 19. Jones Dominique Z, Ragin Camille, Kidd Nayla C, Flores-Obando Rafael E, Jackson Maria, McFarlane-Anderson Norma, Tulloch-Reid Marshall, Kimbro Kevin S, Kidd Lacreis |
| The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients. Hereditary cancer in clinical practice 2013 11 (1): 20. Talseth-Palmer Bente A, Wijnen Juul T, Andreassen Eva K, Barker Daniel, Jagmohan-Changur Shantie, Tops Carli M, Meldrum Cliff, , Spigelman Allan, Hes Frederik J, Van Wezel Tom, Vasen Hans Fa, Scott Rodney |
| Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals. Hereditary cancer in clinical practice 2013 11 (1): 13. Septer Seth, Slowik Voytek, Morgan Ryan, Dai Hongying, Attard Thom |
| Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. European journal of human genetics : EJHG 2012 Dec . Feliubadaló L, Lopez-Doriga A, Castellsagué E, Del Valle J, Menéndez M, Tornero E, Montes E, Cuesta R, Gómez C, Campos O, Pineda M, González S, Moreno V, Brunet J, Blanco I, Serra E, Capellá G, Lázaro C |
| An inherited NBN mutation is associated with poor prognosis prostate cancer. British journal of cancer 2012 Nov . Cybulski C, Woko?orczyk D, Klu?niak W, Jakubowska A, Górski B, Gronwald J, Huzarski T, Kashyap A, Byrski T, D?bniak T, Go??b A, Gliniewicz B, Sikorski A, Swita?a J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przyby?a J, Sosnowski M, Ma?kiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Ró?a?ski W, Ki? J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, S?upski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domaga?a P, Narod SA, Lubi?ski J |
| Chemokine Ligand 5 (CCL5) and Chemokine Receptor (CCR5) Genetic Variants and Prostate Cancer Risk among men of African Descent: A Case-Control Study. Hereditary cancer in clinical practice 2012 Nov 10 (1): 1. Kidd LR, Jones DZ, Rogers EN, Kidd NC, Beache S, Rudd JE, Ragin C, Jackson M, Anderson NM, Reid MT, Morrison S, Brock GN, Barve SS, Kimbro KS |
| Glucocorticoid Receptor and Molecular Chaperones in the Pathogenesis of Adrenal Incidentalomas: Potential Role of Reduced Sensitivity to Glucocorticoids. Molecular medicine (Cambridge, Mass.) 2012 Nov . Damjanovic SS, Antic JA, Ilic BB, Beleslin BB, Ivovic M, Ognjanovic SI, Isailovic TV, Popovic BM, Bozic IB, Tatic S, Matic G, Todorovic VN, Paunovic I |
| Absence of the RET+3:T allele in the MTC patients. Hereditary cancer in clinical practice 2012 Oct 10 (1): 1. Borun P, Jerzy S, Ziemnicka K, Kubaszewski L, Lipinski D, Plawski A |
| Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. Obstetrics and gynecology 2012 Aug 120 (2 Pt 1): 235-40. Schrader Kasmintan A, Hurlburt Jane, Kalloger Steve E, Hansford Samantha, Young Sean, Huntsman David G, Gilks C Blake, McAlpine Jessica |
| Risks of Primary Extracolonic Cancers Following Colorectal Cancer in Lynch Syndrome. Journal of the National Cancer Institute 2012 Aug . Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Marchand LL, Newcomb PA, Hopper JL, Jenkins MA |
| The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. International journal of cancer. Journal international du cancer 2012 Jul 131 (1): 229-34. Lubinski Jan, Huzarski Tomasz, Byrski Tomasz, Lynch Henry T, Cybulski Cezary, Ghadirian Parviz, Stawicka Malgorzata, Foulkes William D, Kilar Ewa, Kim-Sing Charmaine, Neuhausen Susan L, Armel Susan, Gilchrist Dawna, Sweet Kevin, Gronwald Jacek, Eisen Andrea, Gorski Bohdan, Sun Ping, Narod Steven A, |
| Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia. Gene 2012 May 498 (2): 169-76. Levanat Sonja, Musani Vesna, Cvok Mirela Levacic, Susac Ilona, Sabol Maja, Ozretic Petar, Car Diana, Eljuga Domagoj, Eljuga Ljerka, Eljuga Dam |
| DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome. Cancer epidemiology 2012 Apr 36 (2): 183-9. Reeves Stuart G, Meldrum Cliff, Groombridge Claire, Spigelman Allan, Suchy Janina, Kurzawski Grzegorz, Lubinski Jan, Scott Rodney |
| Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Mar 30 (9): 958-64. Win Aung Ko, Young Joanne P, Lindor Noralane M, Tucker Katherine M, Ahnen Dennis J, Young Graeme P, Buchanan Daniel D, Clendenning Mark, Giles Graham G, Winship Ingrid, Macrae Finlay A, Goldblatt Jack, Southey Melissa C, Arnold Julie, Thibodeau Stephen N, Gunawardena Shanaka R, Bapat Bharati, Baron John A, Casey Graham, Gallinger Steven, Le Marchand Loïc, Newcomb Polly A, Haile Robert W, Hopper John L, Jenkins Mark |
| The R337H mutation in TP53 and breast cancer in Brazil. Hereditary cancer in clinical practice 2012 Mar 10 (1): 1. Gomes MC, Kotsopoulos J, Leao de Almeida G, Costa MM, Vieira R, de A G Filho F, Pitombo MB, Leal PR, Royer R, Zhang P, Narod SA |
| Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Feb 30 (4): 372-9. Kaye Stan B, Lubinski Jan, Matulonis Ursula, Ang Joo Ern, Gourley Charlie, Karlan Beth Y, Amnon Amit, Bell-McGuinn Katherine M, Chen Lee-May, Friedlander Michael, Safra Tamar, Vergote Ignace, Wickens Mark, Lowe Elizabeth S, Carmichael James, Kaufman Bel |
| BRAF mutations in thyroid tumors from an ethnically diverse group. Hereditary cancer in clinical practice 2012 10 (1): 10. Schulten Hans-Juergen, Salama Sherine, Al-Mansouri Zuhoor, Alotibi Reem, Al-Ghamdi Khalid, Al-Hamour Osman Abdel, Sayadi Hassan, Al-Aradati Hosam, Al-Johari Adel, Huwait Etimad, Gari Mamdooh, Al-Qahtani Mohammed Hussain, Al-Maghrabi Jaud |
| Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families. Biomarker insights 2012 7 151-7. Kaplun Ludmila, Fridman Aviva Levine, Chen Wei, Levin Nancy K, Ahsan Sidra, Petrucelli Nancie, Barrick Jennifer L, Gold Robin, Land Susan, Simon Michael S, Morris Robert T, Munkarah Adnan R, Tainsky Michael |
| Epidemiologic, clinical, and molecular characteristics of hereditary prostate cancer in latvia. Medicina (Kaunas, Lithuania) 2011 47 (10): 10. Abele A, Vjaters E, Irmejs A, Trofimovi?s G, Miklaševi?s E, Gardovskis J |
| Prevalence of the BRCA1 founder mutation c.5266dup in Brazilian individuals at-risk for the Hereditary Breast and Ovarian Cancer Syndrome. Hereditary cancer in clinical practice 2011 Dec 9 (1): 1. Ewald IP, Izetti PR, Vargas FR, Moreira MA, Moreira AS, Moreira-Filho CA, Cunha DR, Hamaguchi S, Camey SA, Schmidt A, Caleffi M, Koehler-Santos P, Giugliani R, Ashton-Prolla P |
| Association of MMP8 gene variation with an increased risk of malignant melanoma. Melanoma research 2011 Oct 21 (5): 464-8. D?bniak Tadeusz, Jakubowska Anna, Serrano-Fernández Pablo, Kurzawski Grzegorz, Cybulski Cezary, Chauhan Saleena Rani, Laxton Ross C, Maleszka Romuald, Lubinski Jan, Ye S |
| Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Oct 29 (28): 3747-52. Cybulski Cezary, Woko?orczyk Dominika, Jakubowska Anna, Huzarski Tomasz, Byrski Tomasz, Gronwald Jacek, Masoj? Bart?omiej, Deebniak Tadeusz, Górski Bohdan, Blecharz Pawe?, Narod Steven A, Lubi?ski J |
| Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 2010 Dec 31 (12): 2124-6. Pastrello Chiara, Polesel Jerry, Della Puppa Lara, Viel Alessandra, Maestro Rober |
| BRCA1 mutations and colorectal cancer in Poland. Familial cancer 2010 Dec 9 (4): 541-4. Suchy Janina, Cybulski Cezary, Górski Bohdan, Huzarski Tomasz, Byrski Tomasz, D?bniak Tadeusz, Gronwald Jacek, Jakubowska Anna, Woko?orczyk Dominika, Kurzawski Grzegorz, K?adny Józef, Jawie? Arkadiusz, Banaszkiewicz Zbigniew, Wi?niowski Rafa?, Wandzel Piotr, Starzewski Jacek, Lorenc Zbigniew, Korobowicz El?bieta, Krokowicz Piotr, Horbacka Karolina, Lubi?ski Jan, Narod Steven |
| BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Dec 28 (36): 5265-73. Rijnsburger Adriana J, Obdeijn Inge-Marie, Kaas Reinoutje, Tilanus-Linthorst Madeleine M A, Boetes Carla, Loo Claudette E, Wasser Martin N J M, Bergers Elisabeth, Kok Theo, Muller Sara H, Peterse Hans, Tollenaar Rob A E M, Hoogerbrugge Nicoline, Meijer Sybren, Bartels Carina C M, Seynaeve Caroline, Hooning Maartje J, Kriege Mieke, Schmitz Paul I M, Oosterwijk Jan C, de Koning Harry J, Rutgers Emiel J T, Klijn Jan G |
| TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Dec 28 (35): 5188-96. Pfaff Elke, Remke Marc, Sturm Dominik, Benner Axel, Witt Hendrik, Milde Till, von Bueren André O, Wittmann Andrea, Schöttler Anna, Jorch Norbert, Graf Norbert, Kulozik Andreas E, Witt Olaf, Scheurlen Wolfram, von Deimling Andreas, Rutkowski Stefan, Taylor Michael D, Tabori Uri, Lichter Peter, Korshunov Andrey, Pfister Stefan |
| Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients. Journal of the National Cancer Institute 2010 Nov 102 (22): 1724-30. Nielsen Maartje, van Steenbergen Liza N, Jones Natalie, Vogt Stefanie, Vasen Hans F A, Morreau Hans, Aretz Stefan, Sampson Julian R, Dekkers Olaf M, Janssen-Heijnen Maryska L G, Hes Frederik |
| CHEK2 mutations and HNPCC-related colorectal cancer. International journal of cancer. Journal international du cancer 2010 Jun 126 (12): 3005-9. Suchy Janina, Cybulski Cezary, Woko?orczyk Dominika, Oszurek Oleg, Górski Bohdan, Debniak Tadeusz, Jakubowska Anna, Gronwald Jacek, Huzarski Tomasz, Byrski Tomasz, Dziuba Ireneusz, Gogacz Marek, Wi?niowski Rafa?, Wandzel Piotr, Banaszkiewicz Zbigniew, Kurzawski Grzegorz, K?adny Józef, Narod Steven A, Lubi?ski J |
| The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 2010 Jun 121 (3): 639-49. Jakubowska Anna, Rozkrut Dominik, Antoniou Antonis, Hamann Ute, Lubinski J |
| The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2010 Mar 19 (2): 167-71. Woko?orczyk Dominika, Gliniewicz Bartomiej, Stojewski Marcin, Sikorski Andrzej, Z?owocka Elibieta, Debniak Tadeusz, Jakubowska Anna, Górski Bohdan, van de Wetering Thierry, Narod Steven A, Lubi?ski Jan, Cybulski Ceza |
| Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010 Feb 138 (2): 487-92. Capelle Lisette G, Van Grieken Nicole C T, Lingsma Hester F, Steyerberg Ewout W, Klokman Willem J, Bruno Marco J, Vasen Hans F A, Kuipers Ernst |
| Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds. Journal of medical genetics 2010 Feb 47 (2): 99-102. Grindedal Eli Marie, Renkonen-Sinisalo Laura, Vasen Hans, Evans Gareth, Sala Paola, Blanco Ignacio, Gronwald Jacek, Apold Jaran, Eccles Diana M, Sánchez Angel Alonso, Sampson Julian, Järvinen Heikki J, Bertario Lucio, Crawford Gillian C, Stormorken Astrid Tenden, Maehle Lovise, Moller P |
.png)
No hay comentarios:
Publicar un comentario